Preferred Name |
golimumab |
|
Synonyms |
CNTO 148 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C529000 |
|
altLabel |
CNTO 148 CNTO-148 Simponi |
|
cui |
C2684024 C2353893 C2987601 |
|
HM |
D000911 |
|
Inverse of RB |
91X1KLU43E 0 |
|
isa |
http://purl.bioontology.org/ontology/MESH/D000893 |
|
LT |
TRD |
|
Mapped to | ||
MDA |
20080520 |
|
MeSH Frequency |
779 |
|
MMR |
20201221 |
|
notation |
C529000 |
|
PA |
D000079424 D000893 D007166 |
|
prefLabel |
golimumab |
|
SC |
1 |
|
Scope Statement |
Golimumab plus MTX effectively reduces the signs and symptoms of RA and is generally well tolerated in patients with an inadequate response to MTX. |
|
SRC |
Arthritis Rheum. 2008 Apr;58(4):964-75 |
|
TERMUI |
T000966338 T000966337 T720101 T754770 |
|
TH |
US NLM (2020) NLM (2008) FDA SRS (2017) INN (19XX) |
|
tui |
T109 T116 T129 T121 |
Create mapping